alluvi624426 - Profile

About me

Profile

Alluvi, formerly BI 4744, represents a notable advance in weight loss therapy. This dual agonist targeting both glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptors

https://alluvi-research.co.uk/